Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

342 Results

Unlock all the news: Be the first to know and act before the market!
100% Free Registration
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024
AQ
Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference
AQ
Blackstone to Acquire Majority Stake in Priority Software
BU
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
AQ
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum
AQ
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC
AQ
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
AQ
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
AQ
Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer
AQ
Massivit Has Successfully Completed a ~USD 4.95 Million (~18 Million NIS) Capital Raising Through A Rights Issue
PR
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
AQ
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024
AQ
Firering Strategic Minerals starts drilling campaign in Ivory Coast
AN
Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-v8 monoclonal antibody
AQ
Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antibody (CRB-601)
AQ
Massivit to Present Virtually at the 26th Annual Needham Growth Conference on Friday, January 19
PR
Firering signs pact for Atex project drilling to begin next month
AN
Radware Announces New Appointment to Its Board of Directors
AQ
Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
AQ
Corbus Pharmaceuticals Announces Publication of Data for its Novel Cannabinoid Type-1 Receptor Inverse Agonist in a Pre-Clinical Model of Obesity Along with Presentations at Obesity Week 2023
AQ
Wix com : Notice and Proxy Statement with respect to the Company’s Annual General Meeting of Shareholders to be held on November 6, 2023 - Form 6-K
PU
EARNINGS: Biome loss widens; Amicorp focused on growth post-IPO
AN
Firering Strategic posts fundraise as eyes start of drilling campaign
AN
Firering Strategic begins commissioning of Zambia lime plant
AN
Firering Strategic buys stake in former Glencore limestone project
AN
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
AQ
Massivit to Participate in the 12th Annual Needham Industrial Tech, Robotics, & Clean Tech 1x1 Virtual Conference on August 7
PR
Corbus Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
PR
Kornit Digital : NOTICE OF 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 28, 2023 - Form 6-K
PU
Fireing Strategic successfully starts phase 2 auger drilling
AN
Wentworth swings to loss as M&P takeover drags on
AN
Scheme of arrangement for ECSC takeover passes
AN
Corbus Pharmaceuticals to Participate in the 2023 Jefferies Healthcare Conference
PR
Firering completes soil sampling programme; identifies pegmatite
AN
Massivit to Participate in the Inaugural EF Hutton Global Conference on May 10, 2023
PR
NWF beats market view; AFC hydrogen offering progress
AN
Wix Announces Changes to Board of Directors to Support New Phase of Value Creation
PR
Wix Announces Changes to Its Board of Directors
CI
Corbus Pharmaceuticals Reports Fourth Quarter 2022 and Year-End Financial Results and Provides Corporate Update
PR
Corbus Pharmaceuticals Expands Board of Directors with Appointment of Yong Ben, M.D., MBA
PR
Corbus Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
PR
Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC)
PR
Ondas Networks Inc. and American Robotics, Inc. completed the acquisition of Airobotics Ltd..
CI
TRADING UPDATES: Galileo confirms gold zone; Spectral hails results
AN
TRADING UPDATES: Serinus completes rig-up; Xtract concludes JV deal
AN
Kornit Digital : NOTICE OF SPECIAL GENERAL MEETING OF SHAREHOLDERSTO BE HELD ON DECEMBER 29, 2022 - Form 6-K
PU
TRADING UPDATES: Gulf Marine wins deal; Rockpool considers acquisition
AN
Corbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
PR
Wix com : Notice and Proxy Statement with respect to the Company’s Annual General Meeting of Shareholders - Form 6-K
PU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Yuval Cohen
  4. News